81 – 90 of 392
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2015
-
Mark
Four-Year Durability of Initial Combination Therapy with Sitagliptin and Metformin in Patients with Type 2 Diabetes in Clinical Practice; COSMIC Study.
(
- Contribution to journal › Article
- 2014
-
Mark
Conditional glucagon receptor overexpression has multi-faceted consequences for beta-cell function.
(
- Contribution to journal › Article
-
Mark
Efficacy of vildagliptin versus sulfonylureas as add-on therapy to metformin: comparison of results from randomised controlled and observational studies.
(
- Contribution to journal › Article
-
Mark
GLP-1 released to the mesenteric lymph duct in mice: Effects of glucose and fat.
(
- Contribution to journal › Article
-
Mark
Fibroblast Growth Factor 21 (FGF21) and Glucagon Like-Peptide 1 Contribute to Diabetes Resistance in Glucagon Receptor Deficient Mice.
(
- Contribution to journal › Article
-
Mark
Dipeptidyl peptidase-4 (DPP-4): Localization and activity in human and rodent islets.
(
- Contribution to journal › Article
-
Mark
The neuro-incretin concept.
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
Equal improvement in glycaemia with lixisenatide given before breakfast or the main meal of the day.
(
- Contribution to journal › Article
-
Mark
Glucagon dynamics during hypoglycaemia and food-re-challenge following treatment with vildagliptin in insulin-treated patients with type 2 diabetes.
(
- Contribution to journal › Article
-
Mark
The mind and the belly: a glance at how the nervous system directs metabolism
(
- Contribution to journal › Debate/Note/Editorial